Science Explorer Back to mapMap
Discussion
Company · Ness Ziona · Israel

Mapi Pharma (Israel)

mapi-pharma.comROR OpenAlex
Research works
33
▲ 57% vs 2018-21
Citations
870
26.4 per fractional work
Top-10% rate
7.6%
all institutions 10.0%
Open access
45%
world 40%
International
29%
world 18%
Mapi Pharma (Israel)

Not ranked overall: Mapi Pharma (Israel) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Mapi Pharma (Israel) work in?

In all years, 57% of research at Mapi Pharma (Israel) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (22%), Neuroscience (9%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 19 fractional works · 57.1% of its workMedicine: 19 fractional works · 56.3% of its workEpidemiology: 4 fractional works · 11.0% of its workGenetics: 2 fractional works · 7.5% of its workOncology: 2 fractional works · 5.7% of its workRheumatology: 2 fractional works · 4.8% of its workSurgery: 2 fractional works · 4.8% of its workPathology and Forensic Medicine: 1 fractional works · 4.0% of its workPharmacology: 1 fractional works · 3.3% of its workBiochemistry: 1 fractional works · 3.0% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.9% of its workPhysiology: 0 fractional works · 1.5% of its workInfectious Diseases: 0 fractional works · 1.3% of its workUrology: 0 fractional works · 1.2% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workEmergency Medicine: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.2% of its workLife Sciences: 13 fractional works · 39.4% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 22.2% of its workMolecular Biology: 5 fractional works · 15.5% of its workCancer Research: 1 fractional works · 2.4% of its workGenetics: 1 fractional works · 1.9% of its workCell Biology: 0 fractional works · 1.5% of its workEndocrinology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workBiotechnology: 0 fractional works · 0.2% of its workNeuroscience: 3 fractional works · 8.6% of its workNeurology: 2 fractional works · 4.8% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.8% of its workSensory Systems: 0 fractional works · 1.3% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.6% of its workPharmaceutical Science: 1 fractional works · 2.3% of its workPharmacology: 0 fractional works · 1.0% of its workToxicology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workImmunology and Microbiology: 1 fractional works · 2.9% of its workImmunology: 1 fractional works · 2.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 2.0% of its workPlant Science: 0 fractional works · 1.0% of its workAquatic Science: 0 fractional works · 0.8% of its workAnimal Science and Zoology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 2.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.0% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workFinance: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 1.0% of its workHealth: 0 fractional works · 1.0% of its workPhysical Sciences: 0 fractional works · 1.5% of its workEnvironmental Science: 0 fractional works · 0.9% of its workEcology: 0 fractional works · 0.9% of its workChemistry: 0 fractional works · 0.2% of its workSpectroscopy: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.2% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.2% of its workALL ITS WORKMapi Pharma(Israel)33fractional works, all years
Life Sciences39%Physical Sciences1%Health Sciences57%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1956.3%
    2. Health Professions00.5%
    3. Veterinary00.2%
    4. Nursing00.2%
    1. Biochemistry, Genetics and Molecular Biology722.2%
    2. Neuroscience38.6%
    3. Pharmacology, Toxicology and Pharmaceutics13.6%
    4. Immunology and Microbiology12.9%
    5. Agricultural and Biological Sciences12.0%
    1. Economics, Econometrics and Finance01.0%
    2. Social Sciences01.0%
    1. Environmental Science00.9%
    2. Chemistry00.2%
    3. Engineering00.2%
    4. Energy00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.42× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.46× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.67× its world share, 0 worksImmunology and Micro…Neuroscience: 2.67× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.21× its world share, 0 worksPharmacology, Toxico…Engineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.40× its world share, 0 worksEnvironmental ScienceMedicine: 3.43× its world share, 7 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.2×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics8.21×0 works
  2. Immunology and Microbiology3.67×0 works
  3. Biochemistry, Genetics and Molecular Biology3.46×2 works
  4. Medicine3.43×7 works
  5. Neuroscience2.67×0 works
  6. Agricultural and Biological Sciences0.42×0 works
  7. Environmental Science0.40×0 works
  8. Engineering0.04×0 works

Who are the top researchers at Mapi Pharma (Israel)?

Ranked on the quality score, Shai Rubnov, Nadav Bleich Kimelman and Laura Popper lead among researchers whose main affiliation is Mapi Pharma (Israel).

  1. 1 Shai Rubnov Israel · #3,588,897 worldwide 277 citations · 16 works
  2. 2 Nadav Bleich Kimelman Israel · #4,121,550 worldwide 239 citations · 33 works
  3. 3 Laura Popper Israel · #4,707,387 worldwide 32 citations · 15 works
  4. 4 Ehud Marom Israel · #5,473,599 worldwide 32 citations · 23 works
All ranked researchers at Mapi Pharma (Israel)

What are the most cited papers from Mapi Pharma (Israel)?

The most cited paper from Mapi Pharma (Israel) is "Translation of Vascular Endothelial Growth Factor mRNA by Internal Ribosome Entry: Implications for Translation under Hypoxia" (Ilan Stein, Ahuva Itin, Paz Einat et al., 1998), with 500 citations. Next come "Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype" (280) and "Ero1-Lα plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer" (166).

Most cited papers
#PaperReleasedCitations
1 Translation of Vascular Endothelial Growth Factor mRNA by Internal Ribosome Entry: Implications for Translation under Hypoxia Ilan Stein, Ahuva Itin, Paz Einat et al. · Molecular and Cellular Biology Open access Jun 1998 500
2 Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype Uzi Milman, Shany Blum, Chen Shapira et al. · Arteriosclerosis Thrombosis and Vascular Biology Open access 22 Nov 2007 280
3 Ero1-Lα plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer Dalit May, Ahuva Itin, Oded Gal et al. · Oncogene 13 Dec 2004 166
4 Expression of the genes coding for the skeletal muscle and cardiac actins in the heart Yitzhak Mayer, Henryk Hanokh Czosnek, P.E. Zeelon et al. · Nucleic Acids Research Open access 1984 158
5 Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53 Elena A. Komarova, Luda B. Diatchenko, Oskar W. Rokhlin et al. · Oncogene 3 Sep 1998 140
All 68 most cited papers, with filters and sorting

Which keywords describe research at Mapi Pharma (Israel)?

By fractional works in all years, weighted toward what it does more of than the world: Regeneration, Mesenchymal Stem Cells, Epidemiology, Pathogenesis, Differentiation, Immunomodulation, Multipotent and Genomics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Epidemiology5▲ 3.7×20 topics
  2. Regeneration4▲ 62×4 topics
  3. Mesenchymal Stem Cells4▲ 89×2 topics
  4. Oxidative Stress3▲ 4.5×7 topics
  5. Differentiation2▲ 102×2 topics
  6. Pathogenesis2▲ 13×4 topics
  7. Immunomodulation2▲ 48×1 topic
  8. Multipotent2▲ 185×1 topic
  9. Genomics2▲ 19×2 topics
  10. Virus2▲ 56×2 topics
  11. Cancer Immunotherapy2▲ 45×3 topics
  12. H1N12▲ 168×1 topic
  13. Inflammation2▲ 2.6×8 topics
  14. Influenza2▲ 127×1 topic
  15. Immunotherapy2▲ 9.0×6 topics
  16. Innate Immunity2▲ 13×3 topics
  17. Matrix Metalloproteinases1▲ 27×2 topics
  18. Tumor Regression1▲ 45×2 topics
  19. Bioavailability1▲ 22×2 topics
  20. CAR T Cells1▲ 84×1 topic
  21. Cancer Prevention1▲ 16×2 topics
  22. Chimeric Antigen Receptor1▲ 84×1 topic
  23. Nanoparticles1▲ 2.7×6 topics
  24. Neurodegenerative Diseases1▲ 17×2 topics
  25. Antigen Presentation1▲ 32×2 topics
  26. Cartilage1▲ 72×1 topic
  27. Cell Signaling1▲ 9.8×4 topics
  28. Extracellular Matrix1▲ 14×4 topics
  29. Ischemic Stroke1▲ 26×3 topics
  30. Osteoarthritis1▲ 26×1 topic
  31. Antioxidants1▲ 7.1×1 topic
  32. Diagnostic Criteria1▲ 15×2 topics
  33. Free Radicals1▲ 33×1 topic
  34. Gene Therapy1▲ 12×4 topics
  35. Neurodegeneration1▲ 10×5 topics

Which research topics does Mapi Pharma (Israel) publish most on?

By volume in 2022-now: Mesenchymal stem cell research, CAR-T cell therapy research, Phytochemicals and Antioxidant Activities and Multiple Sclerosis Research Studies.

Mesenchymal stem cell re…1Mesenchymal stem cell research: 1 fractional worksCAR-T cell therapy research: 1 fractional worksPhytochemicals and Antioxidant Activities: 1 fractional worksMultiple Sclerosis Research Studies: 1 fractional worksOsteoarthritis Treatment and Mechanisms: 1 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksIon Channels and Receptors: 0 fractional worksTotal Knee Arthroplasty Outcomes: 0 fractional worksIon channel regulation and function: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional works
GeneticsOncologyBiochemistryPathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Mesenchymal stem cell research Genetics 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Phytochemicals and Antioxidant Activities Biochemistry 1 works
  4. 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 1 works
  5. 5 Osteoarthritis Treatment and Mechanisms Rheumatology 1 works
  6. 6 RNA Interference and Gene Delivery Molecular Biology 0 works
  7. 7 Ion Channels and Receptors Sensory Systems 0 works
  8. 8 Total Knee Arthroplasty Outcomes Surgery 0 works
  9. 9 Ion channel regulation and function Molecular Biology 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.0%not open55.0%

World: 40% of research is openly available.

with international co-authors29.0%domestic only71.0%

World: 18% is written across borders.

How has Mapi Pharma (Israel)'s research output changed?

Output in 2022-2025 was 57% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Mapi Pharma (Israel) as a percentage of every work published that year, 0.000030% in 2024.

still counting0.000050%0.00010%0.00015%Mapi Pharma (Israel)0.000086% in 20251990200020102020

Fractional works of Mapi Pharma (Israel) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Ness Ziona

All research institutions in Ness Ziona

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Mapi Pharma (Israel). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.